Chi-Heng Wu

Senior Scientist I, Immunology (Myeloid Biology | In vivo Pharmacology) at Dren Bio

Chi-Heng Wu has a diverse work experience in the field of immunology and biomedical research. Chi-Heng started their career as a Graduate Student Research Assistant at National Taiwan University, where they focused on studying the immune-modulatory effects of dietary factors on allergic asthma. Chi-Heng then pursued a PHD at the same university, conducting research on the effects of folate in regulating immunomodulatory cytokines and examining the immuno-modulatory effects of dietary folate deficiency on Th1/Th2/Treg balance in mouse models.

Moving on, Chi-Heng Wu worked as a Postdoctoral Researcher at the University of California, San Francisco, where they established a drug screening platform using PDX mouse models and long-term primary culture systems for T cell lymphoma. Chi-Heng also genetically characterized these models and identified potential targets for improving therapeutic efficacy.

After their postdoctoral work, Chi-Heng Wu joined Theravance Biopharma US, Inc. as a Scientist, where they contributed to scientific research projects. Chi-Heng then transitioned to Harpoon Therapeutics as a Scientist, working on undisclosed projects.

Currently, Chi-Heng Wu holds the position of Senior Scientist I, Immunology (Myeloid Biology | In Vivo Pharmacology) at Dren Bio, Inc. However, specific details about their roles and responsibilities in this position are not provided in the given information.

In summary, Chi-Heng Wu has gained extensive experience in immunology research, with a focus on immunomodulation, drug screening, and genetic characterization of disease models.

Chi-Heng Wu has an extensive education history in the field of science and technology. Starting in 2002, Wu attended National Taiwan University and earned a Bachelor of Science degree in Biochemical Science and Technology in 2006. Wu continued their studies at the same institution and obtained a Master of Science degree in Microbiology and Biochemistry from 2006 to 2008. Finally, Wu pursued further academic achievements and completed a Ph.D in Biochemical Science and Technology with a focus on Nutritional Science and Immunology at National Taiwan University from 2010 to 2017.

Links

Previous companies

Timeline

  • Senior Scientist I, Immunology (Myeloid Biology | In vivo Pharmacology)

    December, 2022 - present